PHILADELPHIA CHROMOSOME POSITIVE
Clinical trials for PHILADELPHIA CHROMOSOME POSITIVE explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA CHROMOSOME POSITIVE trials appear
Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Tough-to-Treat leukemia
Disease control CompletedThis study tested a combination of two drugs, ibrutinib and blinatumomab, in 19 adults whose B-cell acute lymphoblastic leukemia (B-ALL) had returned or stopped responding to treatment. The goal was to see if the combination could improve remission rates. Participants received bo…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New immunotherapy targets hidden leukemia cells to prevent relapse
Disease control CompletedThis study tested a drug called blinatumomab in 36 adults with B-cell acute lymphoblastic leukemia whose cancer was in remission but still had a small number of leukemia cells detectable (minimal residual disease). The goal was to see if blinatumomab could help keep the cancer fr…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:02 UTC